Aclaris Therapeutics, Inc. (ACRS) SEC filings
ACRS SEC filings moved a median of -0.28% by the close. ACRS SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the ACRS overview →
64 measured ACRS SEC filing events.
Where these ACRS SEC filings landedvs 64 measured ACRS SEC filing reactions
| Middle 50% of ACRS SEC filing reactions | -3.13% to +2.86% |
|---|---|
| Median reaction (to close) | -0.28% |
| Measured reactions | 64 |
Point-in-time · zero look-ahead
Half of the 64 ACRS SEC filing events with a measured close landed between -3.13% and +2.86%; 41% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Aclaris Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -0.33% | -2.80% | |
| Form 8-K Aclaris Therapeutics, For: Aug 06 | SEC filing · Form 8-K | +0.24% | -3.94% | |
| Form S-3ASR Aclaris Therapeutics, | SEC filing · Form S-3ASR | -0.33% | -2.80% | |
| Form 8-K Aclaris Therapeutics, For: Jun 04 | SEC filing · Form 8-K | +0.21% | -7.04% | |
| Form 10-Q Aclaris Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +1.32% | +2.07% | |
| Form 8-K Aclaris Therapeutics, For: May 07 | SEC filing · Form 8-K | -1.07% | +4.29% | |
| Form 8-K Aclaris Therapeutics, For: Apr 28 | SEC filing · Form 8-K | -0.48% | +0.48% | |
| Form ARS Aclaris Therapeutics, For: Dec 31 | SEC filing · Form ARS | +3.32% | +4.12% | |
| Form DEF 14A Aclaris Therapeutics, For: Jun 04 | SEC filing · Form DEF | +3.32% | +4.12% | |
| Form DEFA14A Aclaris Therapeutics, | SEC filing · Form DEFA14A | +3.32% | +4.12% | |
| Form 8-K Aclaris Therapeutics, For: Mar 10 | SEC filing · Form 8-K | -0.14% | -0.57% | |
| Form 8-K Aclaris Therapeutics, For: Mar 09 | SEC filing · Form 8-K | +1.75% | +7.31% | |
| Form 10-K Aclaris Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +0.42% | -6.82% | |
| Form 8-K Aclaris Therapeutics, For: Feb 26 | SEC filing · Form 8-K | -2.84% | -1.26% | |
| Form 8-K Aclaris Therapeutics, For: Jan 12 | SEC filing · Form 8-K | -1.53% | +1.92% | |
| Form 8-K Aclaris Therapeutics, For: Jan 06 | SEC filing · Form 8-K | -1.09% | -3.99% | |
| Form 10-Q Aclaris Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | -2.19% | +2.65% | |
| Form 8-K Aclaris Therapeutics, For: Nov 06 | SEC filing · Form 8-K | -3.06% | -0.87% | |
| Form 8-K Aclaris Therapeutics, For: Oct 14 | SEC filing · Form 8-K | -1.59% | -4.23% | |
| Form 10-Q Aclaris Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +1.27% | +3.82% | |
| Form 8-K Aclaris Therapeutics, For: Aug 07 | SEC filing · Form 8-K | -0.65% | +1.29% | |
| Form 8-K Aclaris Therapeutics, For: Jul 29 | SEC filing · Form 8-K | +8.70% | -4.97% | |
| Form 8-K Aclaris Therapeutics, For: Jun 30 | SEC filing · Form 8-K | -1.72% | -2.07% | |
| Form 8-K Aclaris Therapeutics, For: Jun 05 | SEC filing · Form 8-K | +3.24% | -1.29% | |
| Form S-8 Aclaris Therapeutics, | SEC filing · Form S-8 | +3.24% | -1.29% | |
| Form 10-Q Aclaris Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +3.25% | +0.00% | |
| Form 8-K Aclaris Therapeutics, For: May 08 | SEC filing · Form 8-K | -1.56% | +2.34% | |
| Form ARS Aclaris Therapeutics, For: Dec 31 | SEC filing · Form ARS | +0.84% | +6.72% | |
| Form DEF 14A Aclaris Therapeutics, For: Jun 05 | SEC filing · Form DEF | +0.84% | +6.72% | |
| Form DEFA14A Aclaris Therapeutics, | SEC filing · Form DEFA14A | +0.84% | +6.72% | |
| Form PRE 14A Aclaris Therapeutics, For: Jun 05 | SEC filing · Form PRE | +0.00% | -5.08% | |
| Form EFFECT Aclaris Therapeutics, | SEC filing · Form EFFECT | -3.55% | -9.29% | |
| Form 10-K Aclaris Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -4.74% | +4.74% | |
| Form 8-K Aclaris Therapeutics, For: Feb 27 | SEC filing · Form 8-K | -2.77% | -10.14% | |
| Form S-3 Aclaris Therapeutics, | SEC filing · Form S-3 | -4.74% | +4.74% | |
| Form 8-K Aclaris Therapeutics, For: Jan 13 | SEC filing · Form 8-K | +0.00% | +0.81% | |
| Form EFFECT Aclaris Therapeutics, | SEC filing · Form EFFECT | +1.60% | -0.80% | |
| Form S-3 Aclaris Therapeutics, | SEC filing · Form S-3 | +1.09% | -0.73% | |
| Form D Aclaris Therapeutics, | SEC filing · Form D | +3.35% | -3.09% | |
| Form S-8 Aclaris Therapeutics, | SEC filing · Form S-8 | +4.40% | +5.44% | |
| Form 8-K Aclaris Therapeutics, For: Nov 16 | SEC filing · Form 8-K | +3.42% | +29.22% | |
| Form 10-Q Aclaris Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +1.76% | +7.93% | |
| Form 8-K Aclaris Therapeutics, For: Nov 06 | SEC filing · Form 8-K | +4.02% | +0.89% | |
| Form 10-Q Aclaris Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +1.67% | -2.50% | |
| Form 8-K Aclaris Therapeutics, For: Aug 07 | SEC filing · Form 8-K | +0.00% | -7.03% | |
| Form 8-K Aclaris Therapeutics, For: Jul 16 | SEC filing · Form 8-K | -1.41% | -7.04% | |
| Form 8-K Aclaris Therapeutics, For: Jun 06 | SEC filing · Form 8-K | +0.91% | +6.96% | |
| Form 10-Q Aclaris Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -1.60% | -2.40% | |
| Form 8-K Aclaris Therapeutics, For: May 07 | SEC filing · Form 8-K | -1.60% | -2.40% | |
| Form S-8 Aclaris Therapeutics, | SEC filing · Form S-8 | -1.60% | -2.40% | |
| Form ARS Aclaris Therapeutics, For: Dec 31 | SEC filing · Form ARS | -0.84% | +0.00% | |
| Form DEF 14A Aclaris Therapeutics, For: Jun 06 | SEC filing · Form DEF | -0.84% | +0.00% | |
| Form DEFA14A Aclaris Therapeutics, | SEC filing · Form DEFA14A | -0.84% | +0.00% | |
| Form 8-K Aclaris Therapeutics, For: Mar 14 | SEC filing · Form 8-K | -0.87% | +3.48% | |
| Form 10-K Aclaris Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +6.45% | -3.23% | |
| Form 8-K Aclaris Therapeutics, For: Feb 27 | SEC filing · Form 8-K | +6.45% | -3.23% | |
| Form 8-K Aclaris Therapeutics, For: Jan 31 | SEC filing · Form 8-K | +0.00% | +0.00% | |
| Form 8-K/A Aclaris Therapeutics, For: Jan 15 | SEC filing · Form 8-K | +0.00% | +0.00% | |
| Form 8-K Aclaris Therapeutics, For: Jan 15 | SEC filing · Form 8-K | +0.81% | -3.39% | |
| Form 8-K Aclaris Therapeutics, For: Dec 19 | SEC filing · Form 8-K | -16.79% | -5.71% | |
| Form 8-K Aclaris Therapeutics, For: Nov 13 | SEC filing · Form 8-K | -7.03% | -7.87% | |
| Form 10-Q Aclaris Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +2.21% | +0.92% | |
| Form 8-K Aclaris Therapeutics, For: Nov 06 | SEC filing · Form 8-K | +2.21% | +0.92% | |
| Form 8-K Aclaris Therapeutics, For: Sep 18 | SEC filing · Form 8-K | -1.59% | -1.46% |
Keep exploring
More ACRS: earnings → · analyst actions → · ACRS overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| PRINCIPIA BIOPHARMA INC COMMON (PRNB) | 282 | +0.23% | 59% |
| Arcturus Therapeutics Holdings Inc. (ARCT) | 281 | -0.51% | 36% |
| Anika Therapeutics Inc. (ANIK) | 280 | +0.05% | 51% |
| Coherus Oncology, Inc. (CHRS) | 280 | +0.21% | 52% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.